BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market Apr 16, 2019 Life Science
GenScript Starts Construction of Cell Therapy and Antibody Manufacturing Facility Apr 16, 2019 Life Science
BioSense Acquires China Rights to Rexahn’s Pancreatic Cancer Drug in $226 Million Deal Apr 16, 2019 Life Science
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies Apr 16, 2019 Life Science
Catalent Buys Paragon for $1.2 Billion to Build its Gene Therapy Vector Capabilities Apr 15, 2019 Life Science
Creative Bio of Guangzhou Raises $45 Million for Early Colorectal Cancer Test Apr 12, 2019 Life Science
Cullgen Receives $16 Million Series A Investment to Advance Pipeline of Targeted Protein Degraders Apr 10, 2019 Life Science
